Covid-19
RCT | Metformin, Ivermectin, and Fluvoxamine are not beneficial for obese outpatients with Covid-19.
18 Aug, 2022 | 13:00h | UTCEditorial: Time to Stop Using Ineffective Covid-19 Drugs – New England Journal of Medicine
Commentary on Twitter
In this trial involving overweight or obese outpatients with Covid-19, investigators found that none of three repurposed drugs (metformin, ivermectin, and fluvoxamine) reduced the risk of serious disease. https://t.co/8sd6R7CDK6 pic.twitter.com/bPZ6zeuZSA
— NEJM (@NEJM) August 17, 2022
Retrospective cohort study | Risk of preterm birth, small for gestational age at birth, and stillbirth after covid-19 vaccination during pregnancy.
18 Aug, 2022 | 12:51h | UTCNews Release: No link between COVID-19 vaccination in pregnancy and higher risk of preterm birth or stillbirth – British Medical Journal
Related:
SARS-CoV-2 infection and COVID-19 vaccination in pregnancy – Nature Reviews Immunology
WHO Questions and Answers: COVID-19 vaccines and pregnancy.
COVID vaccines safely protect pregnant people: the data are in.
COVID-19 vaccination in pregnancy—number needed to vaccinate to avoid harm.
Editorial: Covid-19 treatments and vaccines must be evaluated in pregnancy.
AstraZeneca vaccination not linked to reduced fertility rates and adverse birth outcomes.
Study shows high effectiveness of the Pfizer mRNA COVID-19 vaccine in pregnancy.
5 Crucial Things to Know About COVID-19 Vaccines and Pregnancy.
CDC Guidance: Pregnant people should be vaccinated against COVID-19.
Cohort study: Pfizer/BioNTech COVID vaccine associated with 78% lower risk of Covid-19 in pregnancy.
Commentary on Twitter
No link between covid-19 vaccination in pregnancy and higher risk of preterm birth or stillbirth, finds study in @bmj_latesthttps://t.co/XLgFeoWVsp
Findings can help guide decision making about #covid-19 #vaccination during #pregnancy pic.twitter.com/9Pxm0Yv2Mf
— BMJ (@bmj_company) August 18, 2022
Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
18 Aug, 2022 | 12:49h | UTC
Commentary on Twitter
NEW—People with #COVID19 continue to face increased risks of some neurological and psychiatric conditions up to 2 years after infection, according to a study published in @TheLancetPsych: https://t.co/9fD5zMU3hE pic.twitter.com/8YhTKJ9v72
— The Lancet (@TheLancet) August 17, 2022
Guideline | Use of COVID-19 convalescent plasma.
17 Aug, 2022 | 14:28h | UTC
Study suggests long covid symptoms affect 1 in 8 patients.
16 Aug, 2022 | 13:52h | UTCNews Release: Most reliable estimates to date suggest one in eight COVID-19 patients develop long COVID symptoms – Lancet
Commentaries:
Long COVID symptoms affect 1 in 8 adults, some for 2 years – CIDRAP
Covid-19: One in eight adults develops long covid symptoms, study suggests – The BMJ
UK approves updated Moderna vaccine targeting Omicron variant.
16 Aug, 2022 | 13:49h | UTCUK approves updated Moderna vaccine targeting Omicron variant – Associated Press/MedicalXpress
See also: Covid: UK first country to approve dual-strain vaccine – BBC
Living through the psychological consequences of COVID-19 pandemic: a systematic review of effective mitigating interventions.
16 Aug, 2022 | 13:43h | UTC
M-A | Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients.
15 Aug, 2022 | 12:27h | UTCRelated:
Anticoagulants for people hospitalised with COVID‐19 – Cochrane Library
Review | Long COVID headache.
15 Aug, 2022 | 12:25h | UTCLong COVID headache – The Journal of Headache and Pain
Commentary on Twitter
#Headache is among the most frequent symptoms persisting or newly developing after #coronavirus disease 2019 (COVID-19) as part of the so-called long #COVID syndrome. Learn more: https://t.co/v1V2jZBluq pic.twitter.com/X6eAgaOaBF
— European Headache Federation (@EHF_Official) August 4, 2022
Under a http://creativecommons.org/licenses/by/4.0/ license
Review | The COVID-19 pandemic and its consequences for chronic pain.
12 Aug, 2022 | 15:02h | UTCThe COVID-19 pandemic and its consequences for chronic pain: a narrative review – Anaesthesia
Commentary on Twitter
?Time to pay attention to the consequences of persistent pain in patients after any severity of COVID-19, with increased risk of post-intensive care syndrome in patients requiring ICU care?@harshamd5 @ANels_MD @NarouzeMD #FreeForAWeek
?https://t.co/NaafjxCbXz pic.twitter.com/Zj2OGIPniP
— ??????????? (@Anaes_Journal) August 1, 2022
Review | Cardiovascular complications of pregnancy-associated COVID-19 infections.
12 Aug, 2022 | 15:14h | UTCCommentaries:
Cardiovascular Complications of COVID-19 in Pregnancy Reviewed – HealthDay
RECOVERY Trial | Baricitinib in patients admitted to hospital with COVID-19.
3 Aug, 2022 | 14:34h | UTCInvited Commentary: Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality – The Lancet
Related:
WHO recommends two new drugs to treat COVID-19 – World Health Organization
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 – New England Journal of Medicine
Commentary on Twitter
New @TheLancet
The largest trial of baricitinib, a JAK-inhibitor drug repurposed via #AI data mining, reduced Covid mortality and the overall reduction consistent with 8 previous RCTs (~20%)https://t.co/5fHDBBvm3Q pic.twitter.com/GDFzcU26H6— Eric Topol (@EricTopol) July 29, 2022
Under a Creative Commons Attribution (CC BY 4.0) license
Systematic Review | Rapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 infection.
29 Jul, 2022 | 12:39h | UTCRapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 infection – Cochrane Library
Summary: How accurate are rapid antigen tests for diagnosing COVID-19? – Cochrane Library
M-A | Prognosis and persistence of smell and taste dysfunction in patients with covid-19.
28 Jul, 2022 | 13:28h | UTCEditorial: Smell and taste dysfunction after covid-19 – The BMJ
Commentary: The burden of prolonged smell and taste loss in covid-19 – The BMJ
News Release: Millions of covid patients may have long term smell and taste problems – BMJ Newsroom
M-A | Antiviral drug treatment for nonsevere COVID-19.
27 Jul, 2022 | 12:14h | UTCNews Release: Some antivirals used in nonsevere COVID-19 may reduce hospitalizations and deaths – Canadian Medical Association Journal
Commentary: COVID-19 antivirals may cut risk of hospitalization, death – CIDRAP
M-A | Beneficial and harmful effects of monoclonal antibodies for the treatment and prophylaxis of COVID-19.
27 Jul, 2022 | 12:12h | UTC
Cohort Study | Cardiometabolic outcomes up to 12 months after COVID-19 infection.
26 Jul, 2022 | 13:30h | UTCNews Release: COVID-19 patients more likely to develop cardiovascular diseases and diabetes soon after infection – PLOS
Commentaries:
COVID-19 tied to new-onset, short-term heart disease, diabetes – CIDRAP
CVD, Diabetes Spike in Acute Phase of COVID-19 – TCTMD
[PREPRINT] RCT | Inhaled fluticasone not beneficial for outpatients with Covid-19.
25 Jul, 2022 | 13:01h | UTCNews Release: Study finds no benefit to taking fluticasone furoate for COVID-19 symptoms – Duke Clinical Research Institute
Commentary: Asthma Drug Fluticasone Fails as Potential COVID-19 Treatment – HealthDay
Retrospective Cohort Study | Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old.
25 Jul, 2022 | 13:03h | UTCRelated:
Cohort Study | Effectiveness of the Pfizer vaccine against Omicron in children 5 to 11 years of age.
21 Jul, 2022 | 13:28h | UTC
Guideline | Neurological manifestations of post-COVID-19 syndrome.
20 Jul, 2022 | 12:18h | UTC
A prospective study of the association between SARS-CoV-2 infection and COVID-19 vaccination with changes in usual menstrual cycle characteristics.
20 Jul, 2022 | 12:27h | UTC
M-A | Colchicine does not improve outcomes in patients with COVID-19.
20 Jul, 2022 | 12:20h | UTC
Who to vaccinate first? A peek at decision-making in a pandemic.
19 Jul, 2022 | 13:40h | UTCWho to vaccinate first? A peek at decision-making in a pandemic – Nature
A pandemic treaty for equitable global access to medical countermeasures: seven recommendations for sharing intellectual property, know-how and technology.
19 Jul, 2022 | 13:38h | UTC